Paediatric & Neonatal Testing Kits Market Report

The growth is driven by advancements in paediatric & neonatal care and increased medical technology innovations and applications in hospitals, diagnostic centres, maternity and speciality clinics.  According to the 2024 report of WHO, it states that approximately, 500,000 deaths occur due to improper diagnosis and untimely care-seeking, using paediatric & neonatal testing kits provides early diagnosis recognition of clinical signs, symptoms and syndromes, preventing serious bacterial infections, and clinical syndrome. In addition, as estimated by the WHO report of 2024, around 6.9 million incidents of preventive serious bacterial infection have occurred in young infants aged 0-59 days in low- and middle-income countries every year.

However, rising demand for new treatment facilities to provide equipment such as incubators, ventilators and monitors to support safety and regulatory standards for paediatric and neonatal products, for this governments are expanding treatment facilities for early diagnosis and treatment of paediatric and neonatal. For instance, in July 2023, Apollo announced the launch of an advanced intervention treatment facility for paediatric and neonatal intensive care in India, including congenital disorders, gastrointestinal, and neurodevelopmental disorders, renal disease, oncology, liver transplants and cardiac conditions.

The increasing prevalence of pediatric conditions, including congenital disorders and genetic diseases, led to a greater need for diagnostic testing, due to this many health organizations with key players are implementing newborn screening programs and introducing new screening kits, resulting in boosting the demand for neonatal testing kits. For instance, in September 2023, Everylife Foundation for Rare Disease announced to release modernized white paper testing kit for newborns, ensuring that every newborn receives early and life-altering interventions for identified treatable conditions. Furthermore, enhanced healthcare infrastructure and increasing access to healthcare services, particularly in emerging markets, expanded the reach of testing kits, enabling market players to introduce co-effective screening kits. For instance, in September 2023, Mylab announced to launch MyNeoShield, a low-cost newborn screening device, that can detect preventable and detectable inherited metabolic disorders and genetic conditions such as mental retardation, mortality, and lifelong illnesses, offering rational and cost-effective solutions.

• Customized kits based on specific health conditions and developmental stage
• Advances in sensory, data analytics, and digital platform
• Increasing focus on meeting safety standard certificate
• Growing demand for comfort in using testing kits
• Rise in telemedicine allowing remote monitoring and consultancy

Increasing allergy cases in infants and children is one of the challenging factors in the market growth, as allergy-related disorders are among the leading diagnoses of chronic diseases in children. For instance, in March 2023, the FDA announced a product recall for SD Biosensor Pilot COVID-19 At-Home Tests, due to contamination of liquid solution with Enterococcus, Enterobacter, Klebsiella, and Serratia, intended to be used for the qualitative detection of the nucleocapsid protein antigen found in the SARS-CoV-2 virus. Infection from these bacteria can result in false test results and illness with a weakened immune system can occur. In addition, the high cost associated with developing specialized kits, that meet the required safety and quality standards can be high, resulting in hampering market growth and adherence to regulatory requirements. Furthermore, limited awareness among parents and caregivers related to the benefits of pediatric and neonatal testing kits impacts market demand.

Growing emphasis on preventive healthcare, and rising demand for non-invasive early and regular screening testing kits for pediatric and neonatal age groups to identify potential health issues before they become severe, led market players to launch advanced sensory tools, providing easy and fast access to diagnostic results. For instance, in November 2023, Revvity announced to launch EONIS Q System, molecular testing for spinal muscular atrophy and severe combined immunodeficiency in born, providing results in approximately three hours, also uses fewer consumable, one-time use plasticware, under the cost-efficient affordable property.

However, with growing focus on child health, increases the demand for new innovative testing methods, resulting in the launching of new diagnostic and testing devices on online platforms by the government to prevent health issues. For instance, in July 2024, WHO announced to launch of MeDevIS (Medical device information system), an online platform that supports government, regulators, and users in decision-making in selecting medical devices for diagnostics, testing, and treatment of disease and health conditions including maternal, reproductive, newborn and child health and non-communicable diseases such as diabetes, infectious disease and more.

North America dominates the paediatric & neonatal testing kits market, owing to the increasing prevalence of congenital disorders in newborns, resulting in rising research and innovative activity and availability of a wide range of paediatric & neonatal testing kits in the region, supporting market growth. Additionally, the paediatric & neonatal testing kits market in Europe is accounting for significant growth, because of the advanced healthcare sector and rising demand for better healthcare kits with all standard safety certificates, resulting in the launch of new and innovative products by market players to meet the growing demand and providing comfort and benefits to consumers. However, the Asia Pacific’s paediatric & neonatal testing kits market is at a significant rise, due to increasing incidences of critical congenital heart defects such as pulmonary atresia and tricuspid atresia, with the increasing demand for paediatric & neonatal testing products. As any start-ups are entering the paediatric & neonatal testing kits market with innovative products and services and expanding market growth.

The report provides a detailed overview of the paediatric & neonatal testing kits market insights in regions including North America, Latin America, Europe, Asia-Pacific, Oceania, and the Middle East and Africa. The country-specific assessment for the paediatric & neonatal testing kits market has been offered for all regional market shares, along with forecasts, market scope estimates, price point assessment, and impact analysis of prominent countries and regions. Throughout this market research report, Y-o-Y growth and CAGR estimates are also incorporated for every country and region, to provide a detailed view of the paediatric & neonatal testing kits market. These Y-o-Y projections on regional and country-level markets brighten the political, economic and business environment outlook, which are anticipated to have a substantial impact on the growth of the paediatric & neonatal testing kits market. Some key countries and regions included in the paediatric & neonatal testing kits market report are as follows:

• Paediatric & neonatal testing kits market detailed segments and segment-wise market breakdown
• Paediatric & neonatal testing kits market dynamics (Recent industry trends, drivers, restraints, growth potential, opportunities in paediatric & neonatal testing kits industry)
• Current, historical and forthcoming 10 years market valuation in terms of paediatric & neonatal testing kits market size (US$ Mn), volume (Units), share (%), Y-o-Y growth rate, CAGR (%) analysis
• Paediatric & neonatal testing kits market demand analysis
• Paediatric & neonatal testing kits market pricing analysis over the forecast period (by key segment and by region)
• Paediatric & neonatal testing kits market regional insights with region-wise market breakdown
• Competitive analysis – key companies profiling including their market share, product offerings, and competitive strategies.
• Latest developments and innovations in the paediatric & neonatal testing kits market
• Regulatory landscape by key regions and key countries
• Supply chain and value chain analysis in the paediatric & neonatal testing kits market
• Paediatric & neonatal testing kits market sales and distribution strategies
• A comprehensive overview of the parent market
• A detailed viewpoint on the paediatric & neonatal testing kits market forecast by countries
• Mergers and acquisitions in the paediatric & neonatal testing kits market
• Essential information to enhance market position
• Robust research methodology